RT Journal Article
SR Electronic
T1 Impact of the COVID-19 pandemic on infant and pediatric asthma: a multi-center survey using an administrative database in Japan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.29.20240374
DO 10.1101/2020.11.29.20240374
A1 Bun, Seiko
A1 Kishimoto, Kenji
A1 Shin, Jung-ho
A1 Takada, Daisuke
A1 Morishita, Tetsuji
A1 Kunisawa, Susumu
A1 Imanaka, Yuichi
YR 2020
UL http://medrxiv.org/content/early/2020/11/30/2020.11.29.20240374.abstract
AB Background Limited data are available on the relationship between infant and pediatric asthma and severe acute respiratory syndrome coronavirus 2 (COVID-19). Political limitations such as school closure may affect the treatment behavior of pediatric asthma. To investigate the trends of treatment behavior in the field of pediatrics during the COVID-19 pandemic.Methods This is a retrospective observational study using Diagnosis Procedure Combination (DPC) data from the Quality Indicator/Improvement Project (QIP) database. We identified children with asthma aged 15 years or younger who were patients from July 1, 2018, to June 30, 2020. The main outcome was a comparison between asthma patients’ treatment behavior before the COVID-19 pandemic and during the COVID-19 pandemic.We statistically tested the admission volume changes based on the discharge date after adjusting for seasonality through a Fourier term using an interrupted time-series analysis (ITS).Results We identified 10,481 inpatients cases in 67 hospitals and 258,911 out-patients cases in 180 hospitals who were diagnosed with asthma. We performed ITS analysis for inpatients. The reduction in the number of patients during this period was estimated to be 232 (P=0.001). In addition, ITS analysis was performed for patients aged <3 years. The reduced number of patients during this period was estimated to be 155 (P<0.001).Conclusions We found that the number of pediatric asthma patients dramatically decreased during the COVID-19 pandemic. We need to continue research into the trends of pediatric asthma patients after the COVID-19 pandemic in Japan.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by JSPS KAKENHI Grant Number JP19H01075 from the Japan Society for the Promotion of Science and by the GAP Fund Program of Kyoto University to Yuichi Imanaka.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted after obtaining approval from the Kyoto University Hospital Ethics committee of the Kyoto University Graduate School and Faculty of Medicine, according to the guidelines on medical and epidemiological research (No. R0135).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.